Literature DB >> 10450261

Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients.

H Fukuzako1, T Fukuzako, T Hashiguchi, S Kodama, M Takigawa, T Fujimoto.   

Abstract

OBJECTIVE: The authors examined phospholipids and high-energy phosphorus metabolism in the temporal lobes of drug-naive schizophrenic patients.
METHOD: In vivo 31P magnetic resonance spectroscopy was performed on 17 first-episode, drug-naive schizophrenic patients and 17 age- and gender-matched healthy subjects.
RESULTS: Patients showed higher levels of phosphodiesters and lower levels of phosphomonoesters than the comparison group. Phosphocreatine levels were increased in the left temporal lobes of patients.
CONCLUSIONS: The results suggest disturbed membrane phospholipid metabolism in both temporal lobes and decreased energy demands in the left temporal lobes of drug-naive schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450261     DOI: 10.1176/ajp.156.8.1205

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

Review 1.  Genetically mediated brain abnormalities in schizophrenia.

Authors:  Larry J Seidman; Heidi E Wencel
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies.

Authors:  Connor S Haszto; Jeffrey A Stanley; Satish Iyengar; Konasale M Prasad
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-10-01

Review 3.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 4.  Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging.

Authors:  Robert K McNamara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-04-21       Impact factor: 4.006

5.  Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis.

Authors:  Liisa Leppik; Madis Parksepp; Sven Janno; Kati Koido; Liina Haring; Eero Vasar; Mihkel Zilmer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-02       Impact factor: 5.270

6.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

7.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 8.  Deconstructing psychosis with human brain imaging.

Authors:  Raquel E Gur; Matcheri S Keshavan; Stephen M Lawrie
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

9.  Neural models of schizophrenia.

Authors:  S Heckers
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

10.  Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.

Authors:  Dorit Ben-Shachar; Rachel Karry
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.